Atlas Trials

Study to Assess the Safety, Tolerability and Pharmacokinetics of STI-1558 in Healthy Volunteers

Clinical trial NCT05364840 · COMPLETED

Trial details

NCT number
NCT05364840
Sponsor
Sorrento Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19
Start date
2022-06-07
Primary completion
2022-10-18
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.